Cytotools AG vs Value8
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Value8 is the larger company by market value: $14 M against $11 M for Cytotools AG, 1.3 times as much (market caps of Jul 30, 2023). Cytotools AG's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet. Value8's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Cytotools AG T5O.F | Value8 PREVA.AS |
|---|---|---|
| Profile | ||
| Country | 🇩🇪 Germany | 🇳🇱 Netherlands |
| Sector | Financial Services | Financial Services |
| Industry | Asset Management | Asset Management |
| Founded | — | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jul 2023 | Market cap Jul 2023 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Cytotools AG or Value8?
Value8 is the larger company by market value: $14 M against $11 M for Cytotools AG, 1.3 times as much (market caps of Jul 30, 2023). Cytotools AG's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet. Value8's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
More about Cytotools AG
More about Value8
Sources#
Every figure on this page comes from these, with the date shown next to it.